Question 1

What is Teladoc Health's P/S ratio?

Accepted Answer

Teladoc Health (TDOC) P/S ratio is 0.6× as of July 27, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month revenue, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/S ratio calculated?

Accepted Answer

P/S = Market Capitalisation ÷ Trailing Twelve-Month (TTM) Revenue, or equivalently Share Price ÷ TTM Revenue Per Share. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/S ratio?

Accepted Answer

The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.

Question 4

What is a good P/S ratio for Teladoc Health?

Accepted Answer

A "good" P/S depends heavily on profit margin and growth: software and other high-margin businesses often command 5–15× sales, while low-margin retailers and commodity producers typically trade below 1×. Compare against sector peers rather than absolute thresholds. For Teladoc Health specifically, the relevant sector benchmark is the current sector median of 3.4×.

Question 5

Is Teladoc Health's P/S ratio high or low?

Accepted Answer

Teladoc Health's P/S ratio of 0.6× is below its own 5-year average of 2.8× and below the sector median of 3.4×. That places the current reading at the 36th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is Teladoc Health's historical P/S ratio range?

Accepted Answer

In the available daily series, Teladoc Health (TDOC) P/S ratio has ranged from a low of 0.3× in 2026 to a high of 23.5× in 2020. The 5-year average is 2.8× and the 5-year median is 1.3×.

Question 7

What was Teladoc Health's P/S ratio in 2025?

Accepted Answer

Teladoc Health (TDOC) P/S ratio at the end of 2025 was 0.5×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month revenue figure available at that date.

Question 8

Why does Teladoc Health's P/S ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (revenue). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$1.23B	$2.53B	0.5×	-0.1×	Dec 31, 2025
2024	$1.57B	$2.57B	0.6×	-0.8×	Dec 31, 2024
2023	$3.58B	$2.6B	1.4×	-0.2×	Dec 31, 2023
2022	$3.84B	$2.41B	1.6×	-5.6×	Dec 31, 2022
2021	$14.7B	$2.03B	7.2×	-16.2×	Dec 31, 2021
2020	$25.7B	$1.09B	23.5×	+12.5×	Dec 31, 2020
2019	$6.08B	$553M	11.0×	+2.6×	Dec 31, 2019
2018	$3.48B	$418M	8.3×	-0.4×	Dec 31, 2018
2017	$2.03B	$233M	8.7×	+1.7×	Dec 31, 2017
2016	$861M	$123M	7.0×	-1.9×	Dec 31, 2016
2015	$691M	$77.4M	8.9×	-3.1×	Dec 31, 2015
2014	$525M	$43.5M	12.1×	—	Dec 31, 2014


Zimmer Biomet Holdings (ZBH)	2.1×
AptarGroup (ATR)	2.1×
Becton, Dickinson and (BDX)	2.1×
Quest Diagnostics (DGX)	2.0×
Charles River (CRL)	1.9×
IQVIA (IQV)	1.7×
GE HealthCare (GEHC)	1.6×
Labcorp Holdings (LH)	1.6×
Solventum (SOLV)	1.4×
HCA Healthcare (HCA)	1.1×
Viatris (VTRS)	1.1×
UnitedHealth Group (UNH)	0.8×
Baxter International (BAX)	0.8×
DaVita (DVA)	0.7×
Henry Schein (HSIC)	0.6×
Universal Health Services (UHS)	0.6×
Elevance Health (ELV)	0.4×
Molina Healthcare (MOH)	0.3×
McKesson (MCK)	0.3×
Cigna (CI)	0.3×
CVS Health (CVS)	0.2×
Cardinal Health (CAH)	0.2×
Cencora (COR)	0.2×
Humana (HUM)	0.2×
Centene (CNC)	0.1×

P/S Ratio for Teladoc Health (TDOC) 2014-2026

P/S Ratio daily chart for Teladoc Health (TDOC)

Historical P/S Ratio for Teladoc Health (TDOC) from 2014 to 2025

About P/S Ratio at Teladoc Health (TDOC)

Teladoc Health P/S Ratio by Year

Teladoc Health P/S Ratio 2025: 0.5×

Teladoc Health P/S Ratio 2024: 0.6×

Teladoc Health P/S Ratio 2023: 1.4×

Teladoc Health P/S Ratio 2022: 1.6×

Teladoc Health P/S Ratio 2021: 7.2×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

Teladoc Health (TDOC) Key Financials